The influence of smoking on the level of proinflammatory cytokines in patients with COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Proinflammatory cytokines in induced sputum and COPD phenotype Source: Annual Congress 2011 - COPD: human studies Year: 2011
MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
An evaluation of circulating cytokines milieu in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Trefoil factors are increased in sputum and serum from subjects with COPD Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Impact of cytokines on endothelium in COPD patients Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006
Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008
Increased levels of epidermal growth factor in sputum of smoking chronic bronchitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003
Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016
Sputum VEGF level increases with treatment of COPD acute exacerbation Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
Assessment of growth factors production from sputum cell culture and sputum supernatant in COPD patients Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016